Media Releases

2020

12/11/2020

Proteomics inks kidney disease test deal in Mid-East – The West Australian

12/11/2020

Middle East is next market for PromarkerD immunoassay test

05/11/2020

PromarkerD clinical assay performance results published

05/11/2020

Clinical assay performance validates Proteomics kidney test – The West Australian

05/11/2020

Proteomics: ‘Studies Back PromarkerD For Kidney Disease’ – Biotech Daily

04/11/2020

$1.1m tax rebate booster for Proteomics coffers – The West Australian

03/11/2020

Proteomics International Laboratories (ASX:PIQ) receives $1.1M R&D tax refund – The Market Herald

02/11/2020

Rapid oesophageal cancer test – 9 News (Television)

28/10/2020

Proteomics’ $6m cap-raising lures UK institutions – The West Australian

24/10/2020

Proteomics International (ASX:PIQ) to raise $6M for high-tech blood test – The Market Herald

23/10/2020

Proteomics International raises $6m in heavily oversubscribed Placement

20/10/2020

Proteomics signs deal for distribution of PromarkerD in Italy – Biotech Dispatch

16/10/2020

Proteomics strikes kidney disease test deal in Italy – The West Australian

16/10/2020

Proteomics International Inks Italian Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

16/10/2020

Proteomics International Laboratories (ASX:PIQ) signs distribution deal for diabetic kidney disease – The Market Herald

1
…
9
10
11
12
13
14
15
…
25